A critical study sheds light on the growing global burden of esophageal cancer, outlining its significant impact and the imperative to identify the ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...